CLIVE ARTHUR ARCULUS-MEANWELL,DAVID J. SCHNEIDER,JAYNE PRATS,SIMONA SKERJANEC
申请号：
BR112015022070
公开号：
BR112015022070A2
申请日:
2013.05.29
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract methods of treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing percutaneous coronary intervention (pci), comprising administering to the patient a pharmaceutical composition including cangrelor. the method may further compriseing an additional therapeutic agent to the patient, the additional therapeutic agent comprising a p2y12 inhibitor. pharmaceutical compositions useful for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing pci. the pharmaceutical compositions comprising cangrelor. methods of preparing a pharmaceutical composition for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing pci, comprising admixing cangrelor with one or more pharmaceutically acceptable excipients. An ischemic event may include stent thrombosis, myocardial infarction, ischemia-driven revascularization, and mortality. "Methods for treating, reducing the incidence of, and / or preventing ischemic events." These are methods for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing percutaneous coronary intervention (pci) comprising administering to the patient a pharmaceutical composition comprising cangrelor. The method may further comprise administering an additional therapeutic agent to the patient, the additional therapeutic agent comprising a p2y12 inhibitor. pharmaceutical compositions useful for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing pci. the pharmaceutical compositions comprise cangrelor. methods for preparing a pharmaceutical composition for treating, reducing the incidence of, and / or preventing an ischemic event in a patient undergoing pci, comprising admixing cangrelor with one or more pharmaceutically acceptable excipients. An ischemic event may include stent thrombosis, myocardial infarction, ischemia-led revascularization
